骨生検市場：手技タイプ別、用途別、製品タイプ別、ガイダンス技術別、エンドユーザー別、地域別

骨生検市場は、2025年に7億7,260万米ドルと推定され、2032年には11億7,720万米ドルに達すると予測され、2025～2032年にかけてCAGR6.2％で成長すると予測されています。

世界の骨生検市場は、診断目的で骨組織サンプルを採取・分析するための特殊な手技を含む、医療診断業界における重要なセグメントです。骨生検は、原発性骨がん、転移性腫瘍、感染症、代謝性骨疾患など、骨に関連する様々な疾患の診断に利用される重要な医療行為です。これらの処置では、低侵襲技術によって小さな骨組織サンプルを採取し、病理医や腫瘍医が包括的な病理組織学的検査を実施できるようにします。この市場には、針生検、開腹生検、画像ガイド下生検などさまざまな生検法があり、それぞれが特定の臨床要件や患者の状態に合わせて調整されています。CTガイド下生検やMRIガイド下生検などの高度な画像技術は、骨生検手技の精度と安全性に革命をもたらし、診断精度を高めながら患者の不快感を軽減しています。骨がん、骨粗鬆症、その他の骨格障害の世界の有病率の増加により、信頼性の高い骨生検手技に対する需要が大幅に増加しています。ヘルスケアプロバイダーは、最適な組織サンプリングと患者の転帰を確保するため、特殊な針、トレフィン、自動生検システムなど、高度な生検機器への依存度を高めています。先端技術と低侵襲的アプローチの統合は、この特殊な医療市場セグメントにおける技術革新の原動力となっています。

市場力学：

世界の骨生検市場は、効果的な治療計画のために正確な診断手技を必要とする骨がんや転移性疾患の世界的な発生率の上昇など、いくつかの主要因によって推進されています。高齢者は生検の介入を必要とする骨関連疾患の発症リスクが高いため、世界人口の高齢化は市場成長に大きく寄与しています。リアルタイムCTおよびMRIガイダンスシステムを含む画像誘導生検技術の技術的進歩は、患者の不快感を最小限に抑えながら手技の精度を高め、市場の普及を促進しています。新興経済諸国におけるヘルスケア支出の増加と医療インフラの改善は、骨生検市場拡大の大きな成長機会を生み出します。しかし、市場は先進的な生検装置や画像診断システムに関連する高額なコストなど、顕著な抑制要因に直面しており、資源に乏しい医療環境での利用が制限される可能性があります。出血、感染、骨折のリスクなど、骨生検に伴う潜在的な合併症は、一部の患者や医療従事者がこうした診断法を選択することを躊躇させる可能性があります。さらに、高度な画像診断やリキッドバイオプシーなどの代替診断技術が利用可能になったことで、従来の骨生検手技に対する競合課題も生じています。このような制約があるにもかかわらず、手技の複雑さを軽減し患者の転帰を改善する革新的な低侵襲生検技術や自動化システムの開発を通じて、大きな機会が生まれています。個別化医療や精密腫瘍学が重視されるようになったことで、骨組織サンプルの包括的な分子・遺伝子解析を可能にし、標的治療アプローチを可能にする特殊な骨生検技術にさらなる機会が生まれています。

本調査の主な特徴

• 本レポートは、骨生検の世界市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模および複合年間成長率（CAGR%）を掲載しています。
• 異なるセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案マトリクスを説明しています。
• また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の骨生検市場の主要企業プロファイルを掲載しています。
• 本レポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
• 骨生検の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
• 利害関係者は、世界の骨生検市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• 促進要因
• 抑制要因
• 機会
• 影響分析
• 主な発展
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ
• 業界動向

第4章 世界の骨生検市場：手技タイプ別、2020～2032年

• 閉鎖式（経皮的）生検
• 開腹生検

第5章 世界の骨生検市場：用途別、2020～2032年

• がんの診断
• 骨感染症の診断
• 代謝性骨疾患
• 遺伝性疾患
• その他（骨外傷評価など）

第6章 世界の骨生検市場：製品タイプ別、2020～2032年

• 針生検
• 骨生検キット
• 生検ガン
• 外科的生検
• その他の器具・アクセサリー

第7章 世界の骨生検市場：ガイダンス技術別、2020～2032年

• 超音波ガイド下生検
• CTガイド下生検
• MRI誘導生検
• 透視検査またはX線誘導生検

第8章 世界の骨生検市場：エンドユーザー別、2020～2032年

• 病院
• 診断検査室
• 専門クリニック
• 外来手術センター
• その他（学術研究機関等）

第9章 世界の骨生検市場：地域別、2020～2032年

• 北米
  • 米国
  • カナダ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • メキシコ
  • その他ラテンアメリカ
• 欧州
  • ドイツ
  • 英国
  • スペイン
  • フランス
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • ASEAN
  • その他アジア太平洋地域
• 中東
  • GCC諸国
  • イスラエル
  • その他中東
• アフリカ
  • 南アフリカ
  • 北アフリカ
  • 中央アフリカ

第10章 競合情勢

• BD（Becton, Dickinson and Company）
• Medtronic
• Abbott Laboratories
• Stryker Corporation
• Olympus Corporation
• Hologic, Inc.
• Thermo Fisher Scientific
• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• Canon Medical Systems
• Boston Scientific Corporation
• Merit Medical Systems
• Fujifilm Holdings Corporation
• Karl Storz GmbH & Co. KG

第11章 アナリストの推奨事項

• 機会
• アナリストの見解
• Coherent Opportunity Map

第12章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

Bone Biopsy Market is estimated to be valued at USD 772.6 Mn in 2025 and is expected to reach USD 1,177.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2032.

The global bone biopsy market represents a critical segment within the medical diagnostics industry, encompassing specialized procedures designed to extract and analyze bone tissue samples for diagnostic purposes. Bone biopsy procedures are essential medical interventions utilized to diagnose various bone-related conditions, including primary bone cancers, metastatic tumors, infections, and metabolic bone diseases. These procedures involve the extraction of small bone tissue samples through minimally invasive techniques, enabling pathologists and oncologists to conduct comprehensive histopathological examinations. The market encompasses various biopsy methods, including needle biopsy, open biopsy, and image-guided biopsy procedures, each tailored to specific clinical requirements and patient conditions. Advanced imaging technologies such as CT-guided and MRI-guided biopsies have revolutionized the precision and safety of bone biopsy procedures, reducing patient discomfort while enhancing diagnostic accuracy. The growing prevalence of bone cancers, osteoporosis, and other skeletal disorders globally has significantly increased the demand for reliable bone biopsy procedures. Healthcare providers increasingly rely on sophisticated biopsy instruments, including specialized needles, trephines, and automated biopsy systems, to ensure optimal tissue sampling and patient outcomes. The integration of advanced technologies and minimally invasive approaches continues to drive innovation within this specialized medical market segment.

Market Dynamics:

The global bone biopsy market is propelled by several key drivers, including the escalating incidence of bone cancers and metastatic diseases worldwide, which necessitates accurate diagnostic procedures for effective treatment planning. The aging global population contributes significantly to market growth, as elderly individuals face higher risks of developing bone-related disorders requiring biopsy interventions. Technological advancements in imaging-guided biopsy techniques, including real-time CT and MRI guidance systems, enhance procedural accuracy while minimizing patient discomfort, thereby driving market adoption. Increasing healthcare expenditure and improved healthcare infrastructure in developing economies create substantial growth opportunities for bone biopsy market expansion. However, the market faces notable restraints, including the high costs associated with advanced biopsy equipment and imaging systems, which can limit accessibility in resource-constrained healthcare settings. Potential complications associated with bone biopsy procedures, such as bleeding, infection, and fracture risks, may deter some patients and healthcare providers from opting for these diagnostic methods. Additionally, the availability of alternative diagnostic techniques, including advanced imaging modalities and liquid biopsies, poses competitive challenges to traditional bone biopsy procedures. Despite these constraints, significant opportunities emerge through the development of innovative, minimally invasive biopsy technologies and automated systems that reduce procedural complexity and improve patient outcomes. The growing emphasis on personalized medicine and precision oncology creates additional opportunities for specialized bone biopsy techniques that can provide comprehensive molecular and genetic analysis of bone tissue samples, enabling targeted therapeutic approaches.

Key Features of the Study:

• This report provides in-depth analysis of the global bone biopsy market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bone biopsy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include BD (Becton, Dickinson and Company), Medtronic, Abbott Laboratories, Stryker Corporation, Olympus Corporation, Hologic, Inc., Thermo Fisher Scientific, Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Boston Scientific Corporation, Merit Medical Systems, Fujifilm Holdings Corporation, and Karl Storz GmbH & Co. KG.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global bone biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bone biopsy market

Market Segmentation

• Procedure Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Closed (Percutaneous) Biopsy
  • Open Biopsy
• Application Insights (Revenue, USD Mn, 2020 - 2032)
  • Cancer Diagnosis
  • Primary Bone Tumors
  • Metastatic Bone Disease
  • Bone Infection Diagnosis
  • Osteomyelitis
  • Septic Arthritis-related Bone Infections
  • Metabolic Bone Disorders
  • Osteoporosis (Diagnostic Confirmation)
  • Paget Disease of Bone
  • Renal Osteodystrophy
  • Genetic Disorders
  • Others (Bone Trauma Assessment, etc.)
• Product Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Needle Biopsy
  • Fine Needle Aspiration Biopsy (FNAB)
  • Core Needle Biopsy
  • Bone Biopsy Kits
  • Pre-packaged Kits
  • Customized Kits
  • Biopsy Guns
  • Semi-automatic biopsy guns
  • Fully automatic biopsy guns
  • Surgical Biopsy
  • Excisional Biopsy
  • Incisional Biopsy
  • Other Instruments & Accessories
• Guidance Technology Insights (Revenue, USD Mn, 2020 - 2032)
  • Ultrasound-Guided Biopsy
  • CT-Guided Biopsy
  • Conventional CT
  • Cone-beam CT
  • MRI-Guided Biopsy
  • Fluoroscopy or X-ray Guided Biopsy
• End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Hospitals
  • Diagnostic Laboratories
  • Specialty Clinics
  • Ambulatory surgical centers
  • Others (Academic & Research Institutes, etc.)
• Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • BD (Becton, Dickinson and Company)
  • Medtronic
  • Abbott Laboratories
  • Stryker Corporation
  • Olympus Corporation
  • Hologic, Inc.
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Canon Medical Systems
  • Boston Scientific Corporation
  • Merit Medical Systems
  • Fujifilm Holdings Corporation
  • Karl Storz GmbH & Co. KG

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Bone Biopsy Market, By Procedure Type
  • Global Bone Biopsy Market, By Application
  • Global Bone Biopsy Market, By Product Type
  • Global Bone Biopsy Market, By Guidance Technology
  • Global Bone Biopsy Market, By End User
  • Global Bone Biopsy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Bone Biopsy Market, By Procedure Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Closed (Percutaneous) Biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Open Biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Bone Biopsy Market, By Application, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cancer Diagnosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Primary Bone Tumors
    • Metastatic Bone Disease
• Bone Infection Diagnosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Osteomyelitis
    • Septic Arthritis-related Bone Infections
• Metabolic Bone Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Osteoporosis (Diagnostic Confirmation)
    • Paget Disease of Bone
    • Renal Osteodystrophy
• Genetic Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others (Bone Trauma Assessment, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Bone Biopsy Market, By Product Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Needle Biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Fine Needle Aspiration Biopsy (FNAB)
    • Core Needle Biopsy
• Bone Biopsy Kits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Pre-packaged Kits
    • Customized Kits
• Biopsy Guns
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Semi-automatic biopsy guns
    • Fully automatic biopsy guns
• Surgical Biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Excisional Biopsy
    • Incisional Biopsy
• Other Instruments & Accessories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Bone Biopsy Market, By Guidance Technology, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Ultrasound-Guided Biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• CT-Guided Biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Conventional CT
    • Cone-beam CT
• MRI-Guided Biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Fluoroscopy or X-ray Guided Biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Bone Biopsy Market, By End User, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Ambulatory surgical centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others (Academic & Research Institutes, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Bone Biopsy Market, By Region, 2020 - 2032, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Guidance Technology, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Guidance Technology, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Guidance Technology, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Guidance Technology, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Guidance Technology, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Guidance Technology, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• BD (Becton, Dickinson and Company)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Stryker Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Olympus Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Philips Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Canon Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merit Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fujifilm Holdings Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Karl Storz GmbH & Co. KG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us